FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36284211000001108: Braftovi 50mg capsules (Pierre Fabre Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111321201000001116 Braftovi 50mg capsules (Pierre Fabre Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111321301000001113 Braftovi 50mg capsules (Pierre Fabre Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Braftovi 50mg capsules (Pierre Fabre Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Is a Encorafenib 50mg capsules true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has specific active ingredient Encorafenib false Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Is a Braftovi true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has active ingredient Substance with B-Raf inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Braftovi 50mg capsules (Pierre Fabre Ltd) Has specific active ingredient Encorafenib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Braftovi 50mg capsules (Pierre Fabre Ltd) 28 capsule 7 x 4 capsules Has AMP True Braftovi 50mg capsules (Pierre Fabre Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start